QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 0.021
-- x --
-- x --
-- - --
$ 0.02 - $ 0.51
25,000
na
230,481
$ -0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2012 09-30-2012 10-Q
2 08-16-2012 06-30-2012 10-Q
3 05-17-2012 03-31-2012 10-Q
4 04-16-2012 12-31-2011 10-K
5 11-17-2011 09-30-2011 10-Q
6 08-16-2011 06-30-2011 10-Q
7 05-16-2011 03-31-2011 10-Q
8 04-04-2011 12-31-2010 10-K
9 11-15-2010 09-30-2010 10-Q
10 08-17-2010 06-30-2010 10-Q
11 05-17-2010 03-31-2010 10-Q
12 04-01-2010 12-31-2009 10-K
13 11-23-2009 09-30-2009 10-Q
14 08-14-2009 06-30-2009 10-Q
15 05-14-2009 03-31-2009 10-Q
16 03-06-2009 12-31-2008 10-K
17 10-30-2008 09-30-2008 10-Q
18 08-13-2008 06-30-2008 10-Q
19 05-15-2008 03-31-2008 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psyched-mindmeds-nasdaq-debut-pharmadrug-gets-orphan-drug-designation-for-dmt-numinus-launches-clinical-trial-of-naturally-derived-psilocybin

PharmaDrug Inc. (CSE: BUZZ) (Pink: LMLLF) announced an FDA-granted Orphan Drug Designation to its wholly owned subsidiary Sairi...